Zhang Yi, Zhou Shu-yan, Sun Ye-hong, Tu Hui-ying, Qin Xiao-lin, Chen Rui, Li Ti-yuan
Shenzhen People's Hospital, Jinan University, Shenzhen, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Feb;28(2):120-3.
To construct the prokaryotic expression plasmid pGEX-4T-1-BZLF1N-BLRF2, and express it in Escherichia coli.
The EB virus BZLF1N gene and BLRF2 gene were amplified by RT-PCR respectively. Then, the two genes were linked by splicing overlap extension PCR method and inserted into the vector pGEX-4T-1, and the recombinant plasmid pGEX-4T-1-BZLF1N-BLRF2 was transformed into E.coli BL21 (DE3) strain. The expression protein ZtaN-p23 was analysed by SDS-PAGE and immunoreactivity was proved by Western blotting.
Restriction enzyme digestion and DNA sequencing showed recombinant plasmid constructed successfully. The expression product ZtaN-p23 with the molecular weight 46000 was located in the cytoplasm and insoluble. The ZtaN-p23 up to 95% purity was obtained after purified using affinity chromatography. Western blotting showed fusion protein possessed a well bioactivity and specificity.
The fusion gene BZLF1N-BLRF2 is successfully constructed and effectively expressed in E.coli, which lay the foundation for further research on its biological properties and functions.
构建原核表达质粒pGEX-4T-1-BZLF1N-BLRF2,并在大肠杆菌中表达。
分别通过RT-PCR扩增EB病毒BZLF1N基因和BLRF2基因。然后,采用重叠延伸PCR法将这两个基因连接起来,并插入载体pGEX-4T-1中,将重组质粒pGEX-4T-1-BZLF1N-BLRF2转化至大肠杆菌BL21(DE3)菌株中。通过SDS-PAGE分析表达蛋白ZtaN-p23,并通过Western印迹法证明其免疫反应性。
酶切和DNA测序表明重组质粒构建成功。分子量为46000的表达产物ZtaN-p23位于细胞质中且不溶性。使用亲和层析纯化后获得纯度高达95%的ZtaN-p23。Western印迹法表明融合蛋白具有良好的生物活性和特异性。
融合基因BZLF1N-BLRF2成功构建并在大肠杆菌中有效表达,为进一步研究其生物学特性和功能奠定了基础。